Search
Lifileucel
go.drugbank.com/drugs/DB17107ApprovedInvestigationalimmunotherapy composed of a suspension of tumour-derived T cells from the patient [L50171] which undergo isolation, ex vivo expansion, and activation[A263341] Lifileucel was granted accelerated approval by the FDA
Bismuth subnitrate
go.drugbank.com/drugs/DB13209ApprovedWithdrawnThe use of bismuth substrate as an active ingredient in over-the-counter antacids is approved by the FDA.
Bezitramide
go.drugbank.com/drugs/DB01459ApprovedIllicitWithdrawnBezitramide has never been FDA approved and is currently a schedule II drug.
Drospirenone
go.drugbank.com/drugs/DB01395ApprovedInvestigational[L7973] Most recently, it was approved by both Health Canada and the FDA in combination with [Estetrol] as an oral contraceptive therapy. … [A182543,A182552] In 2012, however, a safety statement by the FDA concluded that the increase in the risk of thromboembolism resulting from the use of drospirenone remains unclear, as studies regarding
Adenosine
go.drugbank.com/drugs/DB00640ApprovedInvestigational[L31998] Adenosine was granted FDA approval on 30 October 1989.[L31978]
Mixtures: Ra Sence Loe Cure Solu tion Aloe MaskIsosorbide
go.drugbank.com/drugs/DB09401ApprovedInvestigationalIt was approved by the FDA in 1980, but has since been discontinued.
Teriflunomide
go.drugbank.com/drugs/DB08880ApprovedInvestigationalThe FDA label states an important warning about the risk of hepatoxicity and teratogenicity for patients using teriflunomide.
Levopropoxyphene
go.drugbank.com/drugs/DB06793ApprovedWithdrawn[T133] Levopropoxyphene was developed by Lilly and FDA approved on March 21st, 1962. This drug presented different dosages and it was administered as a capsule or suspension.